London, England. For immediate release-May 11th, 2009
IXICO, Ltd., a global imaging technology and service company, announced today that it has opened its US operations in Chicago, Illinois. The new entity, formally known as IXICO US LLC, is owned in entirety by IXICO, Ltd., of London, England.
IXICO’s US office will provide business development and project management support to its expanding US customer base. The US office will also help facilitate IXICO’s planned expansion of its imaging center network and partnership alliance.
“We are very excited to extend our functional capabilities across the Atlantic, and Chicago provides a perfect central location to support our customers on both coasts,” said Derek Hill, Ph.D., IXICO’s founding CEO. “Chicago also provides a rich environment of imaging expertise at its local universities, as well as a pool of highly educated, well trained professionals in clinical trials project management.”
IXICO US will be managed by Ciaran Mark Cooper, Vice President US Business Development. “Our extended operational footprint is the perfect complement to our expanding business core,” said Cooper. “In addition to our full-service ICRO capabilities, we have recently released several new web-based image management tools that offer terrific value to our customers, both large and small. These tools can help optimize the communication and image management in the execution of imaging trials while providing significant time and cost savings to our clients. Our US expansion is a further indication of our growing business and continuing success.”
About IXICO
IXICO offers a full range of Imaging CRO services including comprehensive, technology-based solutions for the pharmaceutical, biotech and medical device industries across all therapeutic areas and clinical trial phases. IXICO recently released Trial Wire, its free, web-based image management tool. IXICO works within an ISO9001:2000 certified Quality Management System.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.